Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 942.50
+3.90 (0.42%)
Oct 19, 2026, 3:29 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 149.42 billion as of October 19, 2026. Its market cap has decreased by 12.56% in one year.
Market Cap
149.42B
Enterprise Value
172.93B
Revenue
86.08B
Global Rank
n/a
Country Rank
n/a
PE Ratio
42.14
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 149.42B, an increase of 36,637.67%. That is a compound annual growth rate of 25.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 148.36B | -12.85% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 317.66B |
| Piramal Pharma | 262.84B |
| Cohance Lifesciences | 177.54B |
| Alivus Life Sciences | 160.73B |
| Eris Lifesciences | 158.77B |
| Alembic Pharmaceuticals | 155.18B |
| NATCO Pharma | 140.61B |
| Sudeep Pharma | 113.03B |